Histone modifications underlie monocyte dysregulation in patients with systemic sclerosis, underlining the treatment potential of epigenetic targeting.
van der Kroef M, Castellucci M, Mokry M, Cossu M, Garonzi M, Bossini-Castillo LM, Chouri E, Wichers CGK, Beretta L, Trombetta E, Silva-Cardoso S, Vazirpanah N, Carvalheiro T, Angiolilli C, Bekker CPJ, Affandi AJ, Reedquist KA, Bonte-Mineur F, Zirkzee EJM, Bazzoni F, Radstake TRDJ, Rossato M.
van der Kroef M, et al. Among authors: angiolilli c.
Ann Rheum Dis. 2019 Apr;78(4):529-538. doi: 10.1136/annrheumdis-2018-214295. Epub 2019 Feb 6.
Ann Rheum Dis. 2019.
PMID: 30793699